UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000017662 |
|---|---|
| Receipt number | R000020471 |
| Scientific Title | Prevention of future development of diabetes in employees at public schools |
| Date of disclosure of the study information | 2015/06/01 |
| Last modified on | 2020/04/01 18:16:27 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Prevention of future development of diabetes in employees at public schools
Acronym
Prevention of the development of diabetes
Scientific Title
Prevention of future development of diabetes in employees at public schools
Scientific Title:Acronym
Prevention of the development of diabetes
Region
| Japan |
Condition
Condition
IGT
Classification by specialty
| Medicine in general | Endocrinology and Metabolism |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
1)determination of predictors for diabetes incidence
2)characterization of insulin secretion in nondiabetic Japanese people
Basic objectives2
Others
Basic objectives -Others
same as above
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
incidence of diabetes or progression to IGT
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 30 | years-old | <= |
Age-upper limit
| 70 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
employees at public schools who recieved check-ups at Hokuriku Central Hospital since April 2006.
Key exclusion criteria
taking medications for diabetes, post gastrectomy state, taking anticancer drugs, taking stroids, or positive for the serum hepatitis markers.
Target sample size
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Rie Oka |
Organization
Hokuriku Central Hospital
Division name
Internal Medicine
Zip code
Address
Nodera123, Oyabe, 932-8503
TEL
0766-67-1150
ririoka@goo.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Rie Oka |
Organization
Hokuriku Central Hospital
Division name
Internal Medicine
Zip code
Address
Nodera123, Oyabe, 932-8503
TEL
0766-67-1150
Homepage URL
ririoka@goo.jp
Sponsor or person
Institute
Hokuriku Central Hospital
Institute
Department
Personal name
Funding Source
Organization
the Japan Health Promotion Foundation
Organization
Division
Category of Funding Organization
Non profit foundation
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2015 | Year | 06 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Partially published
Result
URL related to results and publications
http://www.ncbi.nlm.nih.gov/pubmed/24151911
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2006 | Year | 03 | Month | 10 | Day |
Date of IRB
| 2017 | Year | 05 | Month | 10 | Day |
Anticipated trial start date
| 2006 | Year | 04 | Month | 01 | Day |
Last follow-up date
| 2019 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
| 2019 | Year | 03 | Month | 31 | Day |
Date trial data considered complete
| 2020 | Year | 03 | Month | 31 | Day |
Date analysis concluded
| 2020 | Year | 03 | Month | 31 | Day |
Other
Other related information
1) Characterization of insulin secresion and sensitivity in IFG and IGT.
http://www.ncbi.nlm.nih.gov/pubmed/22068110
2)ALT is an independent predictor for the progression from NGT to IGT.
http://www.ncbi.nlm.nih.gov/pubmed/24151911
3)One-hour plasma glucose as a predictor of the development of Type 2 diabetes in Japanese adults.
https://www.ncbi.nlm.nih.gov/pubmed/26482027
Management information
Registered date
| 2015 | Year | 05 | Month | 25 | Day |
Last modified on
| 2020 | Year | 04 | Month | 01 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020471
| Research Plan | |
|---|---|
| Registered date | File name |
| Research case data specifications | |
|---|---|
| Registered date | File name |
| Research case data | |
|---|---|
| Registered date | File name |
